+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cerus Corporation - logo

Cerus Corporation is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. Cerus Corporation was founded in 1991 and is headquartered in Concord, California.

From
Embolotherapy Global Market Forecast To - 2029 - Product Thumbnail Image

Embolotherapy Global Market Forecast To - 2029

  • Report
  • January 2023
  • 446 Pages
  • Global
From
From
Global Flow Diverters Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Global Flow Diverters Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
EU5 Radiosurgery Systems Market Outlook to 2025 - Product Thumbnail Image

EU5 Radiosurgery Systems Market Outlook to 2025

  • Report
  • November 2018
  • 61 Pages
  • Europe
From
United Kingdom Radiosurgery Systems Market Outlook to 2025 - Product Thumbnail Image

United Kingdom Radiosurgery Systems Market Outlook to 2025

  • Report
  • October 2018
  • 19 Pages
  • United Kingdom
From
Neurology Devices Global Market Report 2024 - Product Thumbnail Image

Neurology Devices Global Market Report 2024

  • Report
  • February 2024
  • 400 Pages
  • Global
From
From
From
From
From
Global Neurovascular Devices Market 2022-2026 - Product Thumbnail Image

Global Neurovascular Devices Market 2022-2026

  • Report
  • March 2022
  • 120 Pages
  • Global
From
Loading Indicator